Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
CANO FRANCIS | Director | May 31 '24 | Sale | 11.93 | 3,615 | 43,127 | 36,905 | Jun 03 05:37 PM | CANO FRANCIS | Director | May 24 '24 | Option Exercise | 5.90 | 7,500 | 44,250 | 44,405 | May 28 08:18 PM | Burgess Justin | Chief Accounting Officer | Mar 01 '24 | Option Exercise | 10.45 | 7,101 | 74,232 | 20,526 | Mar 04 05:25 PM | Burgess Justin | Chief Accounting Officer | Mar 01 '24 | Sale | 12.78 | 20,526 | 262,322 | 0 | Mar 04 05:25 PM | Janssen Robert | SVP and CMO | Jan 04 '24 | Option Exercise | 9.41 | 1,500 | 14,115 | 51,425 | Jan 08 06:48 PM | Janssen Robert | SVP and CMO | Jan 04 '24 | Sale | 15.00 | 1,500 | 22,500 | 49,925 | Jan 08 06:48 PM | Novack David F | President & COO | Jan 02 '24 | Option Exercise | 5.42 | 9,000 | 48,780 | 12,187 | Jan 04 07:04 PM | Novack David F | President & COO | Jan 02 '24 | Sale | 14.45 | 9,000 | 130,050 | 3,187 | Jan 04 07:04 PM | Novack David F | President & COO | Dec 01 '23 | Option Exercise | 5.42 | 20,000 | 108,400 | 23,187 | Dec 05 07:12 PM | Novack David F | President & COO | Dec 01 '23 | Sale | 13.56 | 20,000 | 271,200 | 3,187 | Dec 05 07:12 PM | Novack David F | President & COO | Nov 03 '23 | Option Exercise | 5.42 | 20,000 | 108,400 | 23,187 | Nov 07 05:16 PM | Novack David F | President & COO | Nov 03 '23 | Sale | 15.00 | 20,000 | 300,000 | 3,187 | Nov 07 05:16 PM | Novack David F | President & COO | Nov 01 '23 | Option Exercise | 5.42 | 20,000 | 108,400 | 23,187 | Nov 03 04:32 PM | Novack David F | President & COO | Nov 01 '23 | Sale | 14.12 | 20,000 | 282,400 | 3,187 | Nov 03 04:32 PM | Janssen Robert | SVP and CMO | Oct 10 '23 | Option Exercise | 9.41 | 1,755 | 16,515 | 51,680 | Oct 11 08:53 PM | Janssen Robert | SVP and CMO | Oct 10 '23 | Sale | 15.01 | 1,755 | 26,343 | 49,925 | Oct 11 08:53 PM | Novack David F | President & COO | Oct 02 '23 | Option Exercise | 5.42 | 40,000 | 216,800 | 43,187 | Oct 04 04:35 PM | Janssen Robert | SVP and CMO | Oct 02 '23 | Option Exercise | 9.41 | 5,015 | 47,191 | 54,940 | Oct 03 08:26 PM | Novack David F | President & COO | Oct 02 '23 | Sale | 14.88 | 40,000 | 595,000 | 3,187 | Oct 04 04:35 PM | Janssen Robert | SVP and CMO | Oct 02 '23 | Sale | 15.03 | 5,015 | 75,375 | 49,925 | Oct 03 08:26 PM | Novack David F | President & COO | Sep 01 '23 | Option Exercise | 5.42 | 20,000 | 108,400 | 23,187 | Sep 05 05:05 PM | Novack David F | President & COO | Sep 01 '23 | Sale | 14.48 | 20,000 | 289,600 | 3,187 | Sep 05 05:05 PM | Janssen Robert | SVP and CMO | Aug 24 '23 | Option Exercise | 9.41 | 600 | 5,646 | 50,525 | Aug 25 06:47 PM | Janssen Robert | SVP and CMO | Aug 24 '23 | Sale | 15.02 | 600 | 9,012 | 49,925 | Aug 25 06:47 PM | Janssen Robert | SVP and CMO | Aug 23 '23 | Option Exercise | 9.41 | 34,857 | 328,004 | 84,782 | Aug 24 12:30 PM | Janssen Robert | SVP and CMO | Aug 23 '23 | Sale | 15.01 | 34,857 | 523,204 | 49,925 | Aug 24 12:30 PM | Novack David F | President & COO | Aug 08 '23 | Option Exercise | 4.41 | 40,000 | 176,550 | 43,187 | Aug 10 11:57 AM | Janssen Robert | SVP and CMO | Aug 08 '23 | Option Exercise | 9.41 | 2,600 | 24,466 | 52,525 | Aug 09 07:26 PM | Hack Andrew A. F. | Director | Aug 08 '23 | Sale | 14.39 | 1,500,000 | 21,585,000 | 915,000 | Aug 10 04:31 PM | Novack David F | President & COO | Aug 08 '23 | Sale | 14.87 | 40,000 | 594,900 | 3,187 | Aug 10 11:57 AM | Janssen Robert | SVP and CMO | Aug 08 '23 | Sale | 15.05 | 2,600 | 39,130 | 49,925 | Aug 09 07:26 PM | Burgess Justin | Chief Accounting Officer | Aug 07 '23 | Option Exercise | 8.16 | 8,061 | 65,767 | 8,061 | Aug 08 04:23 PM | Burgess Justin | Chief Accounting Officer | Aug 07 '23 | Sale | 14.54 | 8,061 | 117,247 | 0 | Aug 08 04:23 PM |
|